News

The supplying of the product follows approval from the US Food and Drug Administration (FDA) its 505(b)(2) new drug application (NDA). Lannett president and CEO Arthur Bedrosian said

Earlier, Wright held major positions in companies like ICI, Glaxo (GSK) and ChiRex. Prior to joining Marken, Wright worked as the chief operating officer of Aptuit, co-founded by

The certificate has been issued by the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) of Mexico Ministry of Health. Prior to the issuing of the certificate,

The mobile version aids consumers to access therapeutic alternative database and allows to view and compare prescription drug savings and safety information at the point of prescription. Mobile

With this new agreement, both the parties have made changes to the previous agreement signed in 2006. The new deal has an initial term ending on 31 December

The changes were made based on a request from Ministry of Health, Labor and Welfare for development of new dosages of Pasetocin. Pasetocin is a broad spectrum antibiotic

Febuxostat is indicated as a treatment for gout and hyperuricemia. The agreement allows Astellas Pharma to sell the product in India, Indonesia, Thailand, the Philippines, Malaysia, Vietnam and

Under the contract, the companies will explore the usage of Anacor’s boron chemistry to discover products for a variety of animal health applications. The research is funded by

The agency plans to complete the whole review process by the date for Bydureon, an experimental medication for type 2 diabetes. Earlier, Amylin and Lilly partnered to develop